AI detection of bladder tumors during cystoscopy
Official title: Artificial Intelligence Detection of Bladder Tumors Under Endoscopy
Run by Peking Union Medical College Hospital · NCT06474338 · Data updated 2026-11-12
This study is testing whether an AI tool can find bladder tumors during cystoscopy better than doctors can.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 31, 2033 |
| Study ends | December 31, 2034 |
| Registry record updated | June 25, 2024 |
| Trial ID | NCT06474338 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients undergoing cystoscopy with observable bladder lesions.
✕Probably not a fit
Patients whose cystoscopy results are unclear and cannot be analyzed will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate whether an AI algorithm can detect bladder tumors more effectively than urologists during cystoscopy. The study will involve annotating cystoscopy videos with both AI and urologist input to compare their detection capabilities. The primary focus is on achieving similar performance metrics, such as precision and recall, between the AI and human observers. By leveraging advanced deep learning techniques, the research seeks to enhance the accuracy of bladder tumor detection, which is critical for effective patient management.
Why it matters
Potential benefit: If successful, this approach could lead to improved detection rates of bladder tumors, potentially reducing recurrence and progression of the disease.
How similar studies have gone: While the application of AI in medical imaging is gaining traction, this specific approach to bladder tumor detection is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: The patient who receives cystoscopy and the cystoscopy video is available, and one or multiple bladder lesions can be observed in the cystoscopy. Exclusion Criteria: The patient whose cystoscopy is not clear enough to analyze.
Where it's running
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Zixing Ye — Peking Union Medical College Hospital
- Study coordinator: Zixing Ye
- Email: yezixing@pumch.cn
- Phone: +86-18611385866
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Calcium electroporation for bladder tumors in adults who can’t have standard treatments
This first‑in‑human study tests intravesical calcium electroporation to see if it is safe and whether it shows early signs of benefit in adults with bladder tumors who have few other options.
-
Using heated socks to prevent hypothermia during bladder tumor surgery
This study tests if wearing heated socks can help keep patients warm and safe during bladder tumor surgery.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Glycogen Storage Disease and Brain Function in People Like You
This study tests whether people with glycogen storage disease perform differently on cognitive tests and show different brain imaging features compared with healthy peers.
-
FAPI PET Imaging to See Fibroblast Activity in Nonischemic Cardiomyopathy
This study tests whether a special PET/CT scan using 18F-AlF-NOTA-FAPI-04 can reveal active fibroblast activity in the hearts of adults with nonischemic cardiomyopathy to help understand disease behavior and guide care.
-
Ivonescimab with GEMOX as neoadjuvant and conversion therapy for biliary tract cancer
This study tests whether adding Ivonescimab to GEMOX can help patients with biliary tract cancer shrink tumors before surgery or enable conversion to operable disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.